Landmark study finds a way to reduce TB treatment regimen down to 4 months
Four months of rifapentine, moxifloxacin, isoniazid, and pyrazinamide for drug-susceptible tuberculosis was shown to be non-inferior to six months of the standard RIPE (rifampin, isoniazid, pyrazinamide, and ethambutol) regimen. Read the NEJM article here for more details, which includes a 3-minute "quick take" video summarizing the randomized trial. Shorter treatment courses help us improve quality of life for patients and get another step closer to TB elimination!
New report on governance of TB in 22 countries
The Stop TB Partnership and the United States Agency for International Development (USAID) released a new report assessing the governance of National TB Programs in 22 countries which together account for over 70% of the global TB burden. The report is envisioned to support and strengthen the performance of national-level action against TB, a preventable and curable disease, which needlessly kills 4,000 people every day.
Welcome to the signup page for all of the Stop TB USA Newsletters! By clicking on the link below you will be prompted to sign up and create a new Friend of Stop TB USA profile.
This is our basic membership level that allows you to receive any or all of our Newsletters, as well as join a working group if you wish participate to a greater degree. Once you have created a profile, and selected your level of interests, you will begin to receive free Stop TB Newsletters and email announcements delivered directly to your inbox, the minute they are published.
You may also use the link below to update your existing profile information and add or delete any Newsletter subscription or working group selection.
Join the Friends of Stop TB USA, and begin to receive any or all of our Newsletters.
The TB Wire is an electronic newsletter, published twice-monthly to update subscribers on funding and leadership issues, calls to action, partner issues and activities, new educational products, and information about TB-related meetings.
Do you or any of your colleagues, policy maker friends, friends in the press, or other acquaintances believe tuberculosis is no longer a problem in the US? Well, this quarterly published newsletter contains TB-related reports that occur every three months, and although they are not all the TB reports and articles, many of these reports describe problems that present significant challenges for health departments.
To read an archived issue of the TB Wire or the TB No Longer a Problem? Newsletter, click here...